Inhaled Tobramycin in BPD

NCT04560179 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Bronchopulmonary Dysplasia

Interventions

DRUG: Tobramycin solution for inhalation 78mg dose
DRUG: Tobramycin solution for inhalation 150mg dose
DRUG: Tobramycin solution for inhalation 216mg dose
DRUG: Tobramycin solution for inhalation 300mg dose

Sponsor

Erik Allen Jensen

Collaborators

[object Object]